Exposure to cigarettes and e-cigarettes: changes in the expression of inflammatory and SARS-CoV-2 viral entry genes

Introduction As of 2026, 11% of the UK adult population smoke tobacco cigarettes and 10% vape e-cigarettes. For pandemic preparedness, it is essential to identify populations that may be at a higher risk of infection to ensure more targeted public health advice. Any association between smoking and SARS-CoV-2 infection remains conflicted and there is limited research on the impact of vaping. Methods A human bronchial epithelial cell line cultured at the air-liquid interface was exposed, via suspension, to e-liquid, e-cigarette condensate or tobacco cigarette condensate to determine any direct impacts on respiratory toxicity or genes relating to viral entry and/or inflammation. Results Results demonstrate that e-cigarette condensate had minimal toxicity compared to tobacco cigarette condensate. Additionally, gene expression changes in-vitro suggest exposure to tobacco cigarette condensate increases infection risk compared to e-cigarette condensate exposure. Conclusion Preliminary investigations with SARS-CoV-2 infection reiterates the differing effects of e-cigarette and tobacco cigarette condensate exposure, highlighting the importance of further investigations in both areas to inform public health advice.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.1952353
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exposure to cigarettes and e-cigarettes: changes in the expression of inflammatory and SARS-CoV-2 viral entry genes

Tim H. Marczylo, Emma L. Marczylo, Alexis Bailey, Karen E. Gooch et al.
Frontiers in Immunology
Smoking Behavior and Cessation
article

Exposure to cigarettes and e-cigarettes: changes in the expression of inflammatory and SARS-CoV-2 viral entry genes

Tim H. Marczylo, Emma L. Marczylo, Alexis Bailey, Karen E. Gooch, Matthew Wright, Atallah El Zein, Rachel Bowsher
article en

Abstract

Introduction As of 2026, 11% of the UK adult population smoke tobacco cigarettes and 10% vape e-cigarettes. For pandemic preparedness, it is essential to identify populations that may be at a higher risk of infection to ensure more targeted public health advice. Any association between smoking and SARS-CoV-2 infection remains conflicted and there is limited research on the impact of vaping. Methods A human bronchial epithelial cell line cultured at the air-liquid interface was exposed, via suspension, to e-liquid, e-cigarette condensate or tobacco cigarette condensate to determine any direct impacts on respiratory toxicity or genes relating to viral entry and/or inflammation. Results Results demonstrate that e-cigarette condensate had minimal toxicity compared to tobacco cigarette condensate. Additionally, gene expression changes in-vitro suggest exposure to tobacco cigarette condensate increases infection risk compared to e-cigarette condensate exposure. Conclusion Preliminary investigations with SARS-CoV-2 infection reiterates the differing effects of e-cigarette and tobacco cigarette condensate exposure, highlighting the importance of further investigations in both areas to inform public health advice.

Frontiers in ImmunologyVol. 17
UK Health Security Agency (GB), City St George's, University of London (GB)
Good health and well-being
Smoking Behavior and Cessation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon